期刊文献+

中国人食管癌 p16 基因突变分析 被引量:7

MUTATION ANALYSIS OF p16 GENE IN ESOPHAGEAL CARCINOMAL IN CHINA
全文增补中
导出
摘要 为了解p16基因与中国人食管癌遗传易感性的关系,应用PCR-SSCP银染法和DNA序列测定法对40例食管癌及相应手术切端正常组织DNA标本p16基因进行研究,结果在40例食管癌标本DNA中共发现DNA变异14例,其中9例存在有p16基因的错义突变和剪接位点突变,5例分别在密码子41和140存在与白种人已发现的相同的正常多态现象,而相应的正常手术切端组织标本中未发现有错义突变和剪接位点突变。提示:(1)中国人食管癌中存在较高频率的p16基因突变,并以错义突变为主;(2)高发区和普通人群食管癌标本中p16基因突变频率未见差异;(3)正常对照手术切端组织未发现相应体细胞突变。表明p16基因突变在中国人食管癌发展过程中属较晚期的改变。 To understand the relationship between p16(MTS1) gene and the susceptibility of esophageal cancer, 40 primary squamous cell carcinomas of esophagous and their paired normal esophageal tissues at the resection ends were detected using PCR SSCP silver stain method and DNA sequencing. 14 mutations were found altogether in these 40 samples. 9 of 40 tumors had missense or splicing site mutations. 5 tumors had polymorphisms at condon 140 and condon 41 respectively. In the matched normal esophageal tissues, no mutation was found. These indicated:(1) high frequency mutations of p16 gene, especially missense mutations, exist in esophageal cancer tissues in Chinese; (2) no difference has been found in the mutation frequencies between high incidence area and normal populations; (3) no somatic mutations have been found in the resection end tissues. The results suggest that p16 gene mutations may play a role at the later stage of tumorigenesis in esophageal cancer in China.
机构地区 中国医学科学院
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 1997年第3期138-141,共4页 Chinese Journal of Medical Genetics
基金 国家肿瘤攻关课题 攀登计划经费资助
关键词 鳞状上皮细胞癌 P16基因 突变频率 食管肿瘤 Esophageal squamous cell p16 gene Mutation frequency
  • 相关文献

参考文献8

二级参考文献2

  • 1张晨美,曹霞云.囊性纤维化病2例报告[J]临床儿科杂志,1993(01).
  • 2(美)J.萨姆布鲁克(J.Sambrook)等著,金冬雁等.分子克隆实验指南[M]科学出版社,1992.

共引文献35

同被引文献41

  • 1陆哲明.p16抑癌基因的发现及研究[J].国外医学(肿瘤学分册),1995,22(6):321-323. 被引量:20
  • 2付国,吕昌龙.p16和p15基因缺失与白血病[J].国外医学(肿瘤学分册),1997,24(1):52-53. 被引量:9
  • 3Reed J A, Loganzo F, Shea C R, et al. loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlated with invasive stage of tumor progression[J].Cancer Res, 1995, 55(13): 2713.
  • 4Zhang Y,Xiong Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53[J]. Mol Cell, 1999,3(5):579-591.
  • 5Ohta M, Nagai H, Shimizl M, et al. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma[J].Cancer Res, 1994,54 (20):5269-5272.
  • 6Travis J. Closing in on melanoma susceptibility gene(s)[J]. Science, 1992,258(5085): 1080- 1081.
  • 7Diaz M O, Rubin C M, Harden A, et al. Deletions of interferon genes in acute lymphoblastic leukemia[J].N Engl J Med, 1990,322(2):77-79.
  • 8James C D, He J, Collins V P, et al. Localization of chromosome 9P homozygous in glioma cell Lines with markers constituting a continuous linkage group[J]. Cancer Res, 1993, 53(16) :3674-3675.
  • 9Cheng J, Jhanwar S C, Lu Y, et al. Homozygous deletions within 9P21 P22 indentify a small critical region fo chromosomalloss in human malignant mesotheliomas[J].Cancer Res, 1993, 53(20):4761-4763.
  • 10Serrano M, Hannon G J, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of Cyclin D1/CDK4[J].Nature, 1993, 366(6456):704-707.

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部